Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Pharmaxis Ltd ( (AU:SNT) ) has provided an update.
Syntara Limited, an Australian company listed on the ASX, announced the issuance of 44,028,744 new fully paid ordinary shares at an issue price of A$0.06 per share. This move follows the company’s earlier receipt of firm commitments to raise approximately A$15 million through a two-tranche placement. The issuance was conducted without disclosure to investors under specific provisions of the Corporations Act, and the company confirms compliance with relevant legal requirements, indicating a strategic step in capital raising to support its operations.
More about Pharmaxis Ltd
YTD Price Performance: 7.50%
Average Trading Volume: 5,375,335
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$135.8M
See more data about SNT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue